In 2024, lung cancer treatment saw significant strides, including the approval of ensartinib for ALK-positive NSCLC and tarlatamab for SCLC. Advances also included December approvals, promising ADC ...

The vial in my hand contains just one millilitre of blood - barely enough to fill a thimble. But by tomorrow it could reveal ...

Guam Regional Medical City announced the addition of Dr. Supannee "Jill" Rassameehiran, a board-certified gastroenterologist, ...